Trial-Based Costs for Interventions to Improve HPV Vaccine Uptake

This economic evaluation estimates the implementation costs and cost per additional patient receiving the vaccine associated with each of the intervention strategies for increasing rates of human papillomavirus (HPV) vaccination in primary care practices.

Corresponding Author: Anna Hung, PharmD, PhD, MS, Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27701 (anna.hung@duke.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.